Literature DB >> 27587625

Ovarian Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology.

Robert J Morgan, Deborah K Armstrong, Ronald D Alvarez, Jamie N Bakkum-Gamez, Kian Behbakht, Lee-May Chen, Larry Copeland, Marta Ann Crispens, Maria DeRosa, Oliver Dorigo, David M Gershenson, Heidi J Gray, Ardeshir Hakam, Laura J Havrilesky, Carolyn Johnston, Shashikant Lele, Lainie Martin, Ursula A Matulonis, David M O'Malley, Richard T Penson, Sanja Percac-Lima, Mario Pineda, Steven C Plaxe, Matthew A Powell, Elena Ratner, Steven W Remmenga, Peter G Rose, Paul Sabbatini, Joseph T Santoso, Theresa L Werner, Jennifer Burns, Miranda Hughes.   

Abstract

This selection from the NCCN Guidelines for Ovarian Cancer focuses on the less common ovarian histopathologies (LCOHs), because new algorithms were added for LCOHs and current algorithms were revised for the 2016 update. The new LCOHs algorithms include clear cell carcinomas, mucinous carcinomas, and grade 1 (low-grade) serous carcinomas/endometrioid epithelial carcinomas. The LCOHs also include carcinosarcomas (malignant mixed Müllerian tumors of the ovary), borderline epithelial tumors (also known as low malignant potential tumors), malignant sex cord-stromal tumors, and malignant germ cell tumors.
Copyright © 2016 by the National Comprehensive Cancer Network.

Entities:  

Mesh:

Year:  2016        PMID: 27587625     DOI: 10.6004/jnccn.2016.0122

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN: 1540-1405            Impact factor:   11.908


  82 in total

1.  Lymphopenia after induction chemotherapy correlates with incomplete surgical resection in patients with advanced ovarian cancer.

Authors:  Yasunori Yoshino; Ayumi Taguchi; Maki Takao; Tomoko Kashiyama; Akiko Furusawa; Masaya Uno; Satoshi Okada; Nao Kino; Toshiharu Yasugi
Journal:  Int J Clin Oncol       Date:  2018-11-30       Impact factor: 3.402

2.  Impact of National Cancer Institute Comprehensive Cancer Centers on ovarian cancer treatment and survival.

Authors:  Robert E Bristow; Jenny Chang; Argyrios Ziogas; Belinda Campos; Leo R Chavez; Hoda Anton-Culver
Journal:  J Am Coll Surg       Date:  2015-02-14       Impact factor: 6.113

Review 3.  A brief review of the management of platinum-resistant-platinum-refractory ovarian cancer.

Authors:  Bryan Oronsky; Carolyn M Ray; Alexander I Spira; Jane B Trepel; Corey A Carter; Hope M Cottrill
Journal:  Med Oncol       Date:  2017-04-25       Impact factor: 3.064

4.  CT texture analysis in histological classification of epithelial ovarian carcinoma.

Authors:  He An; Yiang Wang; Esther M F Wong; Shanshan Lyu; Lujun Han; Jose A U Perucho; Peng Cao; Elaine Y P Lee
Journal:  Eur Radiol       Date:  2021-01-06       Impact factor: 5.315

5.  Perspectives on molecular signaling in cancer and update on therapeutic options for the treatment of metastatic cancer.

Authors:  Khalid Sossey-Alaoui
Journal:  Ann Transl Med       Date:  2020-07

6.  Triple Synchronous Malignancies in Genital Tract; Primary Endometrial, Ovarian and Fallopian Tube Carcinoma: A Case Report.

Authors:  Ozgur Kan; Aysegul Alkilic; Batuhan Turgay; Ali Gemici; Cem Somer Atabekoglu
Journal:  J Clin Diagn Res       Date:  2017-01-01

7.  Prognostic value of miliary versus non-miliary sub-staging in advanced ovarian cancer.

Authors:  Kevin H Eng; Kayla Morrell; Kristen Starbuck; Chandra Spring-Robinson; Aalia Khan; Dana Cleason; Levent Akman; Emese Zsiros; Kunle Odunsi; J Brian Szender
Journal:  Gynecol Oncol       Date:  2017-05-08       Impact factor: 5.482

Review 8.  Lymphedema secondary to melanoma treatments: diagnosis, evaluation, and treatments.

Authors:  Azuelos Arié; Takumi Yamamoto
Journal:  Glob Health Med       Date:  2020-08-31

9.  Observed-to-expected ratio for adherence to treatment guidelines as a quality of care indicator for ovarian cancer.

Authors:  Valerie B Galvan-Turner; Jenny Chang; Argyrios Ziogas; Robert E Bristow
Journal:  Gynecol Oncol       Date:  2015-09-24       Impact factor: 5.482

10.  Significance of lymph node ratio on survival of women with borderline ovarian tumors.

Authors:  David J Nusbaum; Rachel S Mandelbaum; Hiroko Machida; Shinya Matsuzaki; Lynda D Roman; Anil K Sood; David M Gershenson; Koji Matsuo
Journal:  Arch Gynecol Obstet       Date:  2020-04-17       Impact factor: 2.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.